ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $425,000 | -34.2% | 28,949 | -9.5% | 0.01% | -52.9% |
| Q4 2021 | $646,000 | -45.0% | 32,000 | -26.0% | 0.02% | -22.7% |
| Q3 2021 | $1,175,000 | +12.2% | 43,258 | +0.6% | 0.02% | +15.8% |
| Q2 2021 | $1,047,000 | +296.6% | 43,017 | +421.3% | 0.02% | +280.0% |
| Q4 2020 | $264,000 | -75.2% | 8,252 | -74.4% | 0.01% | -84.4% |
| Q3 2020 | $1,063,000 | -12.2% | 32,230 | +24.5% | 0.03% | -44.8% |
| Q2 2020 | $1,211,000 | – | 25,878 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |